ID: ALA5186863

Max Phase: Preclinical

Molecular Formula: C30H47NO8

Molecular Weight: 549.71

Associated Items:

Representations

Canonical SMILES:  CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@H](CC(C)(C)O)C[C@@]3(CO3)[C@@H]2O)O[C@@H]1C

Standard InChI:  InChI=1S/C30H47NO8/c1-18(9-12-26-28(34)30(17-36-30)16-23(39-26)15-29(6,7)35)8-11-25-19(2)14-24(21(4)38-25)31-27(33)13-10-20(3)37-22(5)32/h8-10,12-13,19-21,23-26,28,34-35H,11,14-17H2,1-7H3,(H,31,33)/b12-9+,13-10-,18-8+/t19-,20-,21+,23+,24+,25-,26+,28+,30+/m0/s1

Standard InChI Key:  YDDGOVRUVVWGJP-JXAFQLEPSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 549.71Molecular Weight (Monoisotopic): 549.3302AlogP: 3.13#Rotatable Bonds: 10
Polar Surface Area: 126.85Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.91CX Basic pKa: CX LogP: 1.92CX LogD: 1.92
Aromatic Rings: 0Heavy Atoms: 39QED Weighted: 0.16Np Likeness Score: 2.58

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source